Stichting Pensioenfonds ABP

“Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version”

By Ralph Turchiano on October 12, 2013 • ( 1 )

$688 Million Settlement Approved in Merck Case By ROSE BOUBOUSHIAN (CN) – Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version, a federal judge ruled. The… Read More ›

Engineering Evil

Intel Portal for Weighted Data and Information ( ARCHIVED – HISTORICAL)

Stichting Pensioenfonds ABP

“Merck and Schering-Plough must pay $688 million for lying to shareholders about the benefits of cholesterol drug Vytorin over its cheaper, generic version”